Latest

neuropharmacology

·September 4, 2024·5 min read

Novel Drug Shows Promise in Preventing Early Alzheimer’s Brain Changes

A recent study has shown that troriluzole can prevent early-stage brain changes in a mouse model of Alzheimer’s disease. The research demonstrated that troriluzole reduces harmful glutamate levels, preserving memory and cognitive function.

Featured Neurology Neuroscience Pain

·August 30, 2024·3 min read

Morphine’s Pain Relief Mechanism Unveiled

Researchers have uncovered how morphine relieves pain by activating a specific group of neurons in the brain, termed the 'morphine ensemble.' These neurons, located in the rostral ventromedial medulla (RVM), connect to the spinal cord and inhibit pain signaling. Understanding this pathway could help reduce the severe side effects of morphine, such as addiction and overdose. The findings also provide insights into the differences between pain relief and the euphoric effects of morphine.

Featured Neurology Neuroscience

·August 6, 2024·5 min read

Dopamine Treatment Reduces Alzheimer’s Plaques

Researchers uncovered a promising approach to treating Alzheimer’s disease by using dopamine to enhance brain enzyme activity that reduces harmful plaques. Conducted on mice, the study shows that dopamine increases neprilysin production, which breaks down beta-amyloid plaques linked to Alzheimer's.

This shows a brain surrounded by seaweed.

Featured Neurology Neuroscience

·August 5, 2024·3 min read

Seaweed Antioxidants Show Promise in Preventing Parkinson’s

Researchers have found that antioxidants from Ecklonia cava, a type of seaweed, may help prevent Parkinson's disease by protecting dopamine-producing neurons. In mouse models, these antioxidants restored motor function and improved gut health after exposure to toxins. Cellular studies revealed that these compounds activate the AMPK enzyme and reduce harmful reactive oxygen species, potentially offering a new approach to combat neurodegeneration. This discovery highlights the potential of Ecklonia cava as a preventive ingredient against Parkinson's disease.

Featured Genetics Neurology Neuroscience

·August 5, 2024·5 min read

Genetically Engineered Parasite Delivers Drugs to the Brain

Researchers genetically engineered the parasite Toxoplasma gondii to deliver drugs across the blood-brain barrier. This innovative approach has been used to deliver therapeutic proteins to neurons, showing promise for treating neurological conditions like Rett syndrome. The research highlights the potential for parasites to act as delivery vehicles for large molecules that typically struggle to penetrate the brain. This breakthrough could lead to new treatments for a variety of neurological disorders.

Featured Neurology Neuroscience

·August 5, 2024·7 min read

New Multiple Sclerosis Drug Regenerates Myelin, Improves Movement

A new drug, PIPE-307, shows promise in reversing multiple sclerosis (MS) damage by promoting myelin regeneration around nerve cells, potentially restoring movement and function. Developed by researchers, this innovative therapy targets a specific receptor, M1R, and has already demonstrated success in animal models. PIPE-307 is currently in Phase II clinical trials, offering hope for a groundbreaking treatment that could stop and even heal the damage caused by MS. This novel approach could transform the future of MS therapy by addressing both symptoms and underlying damage.

Autism Brain Cancer Featured Neuroscience

·July 25, 2024·8 min read

Cancer Drug Shows Promise for Autism Cognitive Function

A new experimental cancer drug could ease cognitive difficulties for those with Rett syndrome, a rare autism-linked disorder, by enhancing brain cell functions. The drug, ADH-503, improves the activity of microglia, which are crucial for maintaining neural networks.

Featured Genetics Neuroscience

·July 15, 2024·5 min read

Adjusting Proteins Increases Ozempic’s Effectiveness

Adjusting melanocortin proteins in the brain enhances the effectiveness of GLP-1 diabetes and weight-loss drugs. By inhibiting MC3R or activating MC4R, mice showed increased sensitivity to these drugs, leading to more significant weight loss and reduced feeding without additional side effects.

Featured Neuroscience Open Neuroscience Articles

·July 15, 2024·6 min read

OpenScope Project Unveils Brain’s Secrets

The OpenScope program is investigating neural activity through four new projects, exploring topics like psilocybin's effects, motion perception, visual texture recognition, and subtle changes in appearance. By using advanced imaging techniques in mice, researchers aim to understand how the brain processes these complex functions.

Featured Neurology Neuroscience

·July 15, 2024·5 min read

Anesthesia Induces Unconsciousness by Destabilizing Brain Activity

Neuroscientists have discovered that the anesthesia drug propofol causes unconsciousness by disrupting the brain's balance between stability and excitability. The drug leads to increasingly unstable brain activity, preventing the brain from maintaining normal consciousness.

Featured Neurology Neuroscience

·July 12, 2024·5 min read

Ozempic Reduces Dementia Risk, Curbs Nicotine Cravings

A new study finds that semaglutide, known as Ozempic/Wegovy, does not negatively impact brain health and may reduce cognitive problems and nicotine dependence. The analysis, using over 100 million patient records, revealed no increased risk of neurological or psychiatric conditions compared to other antidiabetic medications. These findings suggest semaglutide's benefits may extend beyond diabetes management. Further research is needed to confirm these potential benefits.

Featured Neuroscience Visual Neuroscience

·July 3, 2024·7 min read

Ozempic Linked to Increased Risk of Blinding Eye Condition

A new study reveals that patients prescribed semaglutide (Ozempic or Wegovy) for diabetes or weight loss have a higher risk of developing NAION, a potentially blinding eye condition. Diabetic patients on semaglutide were over four times more likely to be diagnosed with NAION, while overweight patients were over seven times more likely. The findings suggest the need for careful discussions between patients and doctors about this risk. NAION remains a rare but serious condition with no effective treatments.

1 … 10 11 12 13 14 … 81

neuropharmacology

Novel Drug Shows Promise in Preventing Early Alzheimer’s Brain Changes

Morphine’s Pain Relief Mechanism Unveiled

Dopamine Treatment Reduces Alzheimer’s Plaques

Seaweed Antioxidants Show Promise in Preventing Parkinson’s

Genetically Engineered Parasite Delivers Drugs to the Brain

New Multiple Sclerosis Drug Regenerates Myelin, Improves Movement

Cancer Drug Shows Promise for Autism Cognitive Function

Adjusting Proteins Increases Ozempic’s Effectiveness

OpenScope Project Unveils Brain’s Secrets

Anesthesia Induces Unconsciousness by Destabilizing Brain Activity

Ozempic Reduces Dementia Risk, Curbs Nicotine Cravings

Ozempic Linked to Increased Risk of Blinding Eye Condition

How Scientists Cracked the Ketamine Code for Depression

Brain Prioritizes “Sound Offsets” During Hearing Repair

Glucose Levels Signal the Growth of Myelin

Why Your Brain “Dreams” Even When You’re Awake

Subscribe